MacroGenics, Inc. (MGNX)

MacroGenics Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	43.36	58.75	151.94	77.45	104.88	64.19
Revenue Growth (YoY)	-73.78%	-61.33%	96.19%	-26.16%	63.40%	6.76%
Cost of Revenue	6.82	8.22	7.38	2.65	0	0
Gross Profit	36.54	50.53	144.56	74.8	104.88	64.19
Selling, General & Admin	53.37	52.19	58.95	63.01	42.74	46.06
Research & Development	166.74	166.58	207.03	214.58	193.2	195.31
Operating Expenses	220.11	218.77	265.98	277.59	235.94	241.37
Operating Income	-183.57	-168.24	-121.42	-202.8	-131.06	-177.19
Interest Expense / Income	1.91	1.43	0	0	0	0
Other Expense / Income	-162.24	-160.62	-1.66	-0.68	-1.32	-25.37
Pretax Income	-23.24	-9.06	-119.76	-202.12	-129.74	-151.81
Net Income	-23.24	-9.06	-119.76	-202.12	-129.74	-151.81
Shares Outstanding (Basic)	62	62	61	60	52	48
Shares Outstanding (Diluted)	62	62	61	60	52	48
Shares Change	0.78%	0.81%	2.48%	14.31%	9.07%	17.49%
EPS (Basic)	-0.38	-0.15	-1.95	-3.37	-2.47	-3.16
EPS (Diluted)	-0.39	-0.15	-1.95	-3.37	-2.47	-3.16
Free Cash Flow	-113.82	-79.91	-90.58	-150.03	-117.8	-138.56
Free Cash Flow Per Share	-1.83	-1.29	-1.47	-2.50	-2.25	-2.88
Gross Margin	84.28%	86.00%	95.14%	96.58%	100.00%	100.00%
Operating Margin	-423.39%	-286.38%	-79.91%	-261.85%	-124.96%	-276.04%
Profit Margin	-53.60%	-15.42%	-78.82%	-260.97%	-123.70%	-236.51%
Free Cash Flow Margin	-262.51%	-136.01%	-59.62%	-193.72%	-112.32%	-215.86%
EBITDA	-9.66	5.51	-104.55	-188.17	-117.78	-139.51
EBITDA Margin	-22.29%	9.37%	-68.81%	-242.96%	-112.30%	-217.34%
Depreciation & Amortization	11.67	13.13	15.21	13.95	11.96	12.31
EBIT	-21.33	-7.63	-119.76	-202.12	-129.74	-151.81
EBIT Margin	-49.20%	-12.98%	-78.82%	-260.97%	-123.70%	-236.51%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).